Immune Thrombocytopenia in Dogs: Treatment and Monitoring

Primary immune thrombocytopenia is a potentially fatal platelet disorder requiring aggressive initial treatment and careful long-term monitoring.

Key Facts

IMT causes platelet counts to fall below 30,000/ul in severe cases, causing spontaneous bleeding
Petechiae, ecchymoses, nosebleeds, and blood in urine or feces indicate severe thrombocytopenia
Life-threatening complications include intracranial hemorrhage and pulmonary hemorrhage
Treatment requires immunosuppressive prednisolone, with vincristine added for rapid platelet increase
Additional immunosuppressants (azathioprine, mycophenolate) support long-term remission
Platelet count monitoring every 48-72 hours during acute phase guides treatment response
Splenectomy is considered in refractory cases as the spleen is a major site of platelet destruction

Welfare Considerations

Severe IMT creates a hemorrhagic crisis - dogs at risk of spontaneous bleeding into vital organs face life-threatening danger. The fear and physical distress of acute hemorrhage is profound. Aggressive treatment brings rapid welfare improvement when successful - platelet counts recovering over days of treatment. Long-term management to prevent relapse maintains welfare without continuous acute risk. Owner education about monitoring for hemorrhage signs between rechecks enables early detection of deterioration.

What You Can Do

Begin immunosuppressive treatment immediately on diagnosis - delay increases hemorrhage risk
Restrict activity strictly during the acute phase - exercise increases hemorrhage risk
Monitor for hemorrhage signs daily at home - report gum paleness, new bruising, or behavioral changes
Follow platelet monitoring schedules exactly - counts can drop rapidly between appointments
Discuss long-term remission management with a veterinary internal medicine specialist